HomeAI · summaries
Storia in 2 fonti
Ozempic, Wegovy may lower fracture risk in diabetes patients
A recent study reveals that semaglutide, the active ingredient in Ozempic and Wegovy, may enhance bone strength in Type 2 diabetes patients while aiding weight loss.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
newsbytesapp.com
Ozempic, Wegovy may lower fracture risk in diabetes patients
A recent study reveals that semaglutide, the active ingredient in Ozempic and Wegovy, may enhance bone strength in Type 2 diabetes patients while aiding weight loss.
- ·
healio.com
Semaglutide linked to lower fracture risk than other drugs in type 2 diabetes
CHICAGO — Adults with type 2 diabetes may have lower risk for fractures if they use semaglutide compared with other medications, according to data presented at ENDO 2026. As…